During the past decade, Shanghai Putuo District Central Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Putuo District Central Hospital" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Changhai Hospital" with 2 trials sponsored, "Ruijin Hospital" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Putuo District Central Hospital" #1 collaborator was "Gongli Hospital" with 2 trials as a collaborator, "No. 904 Hospital of the PLA Joint Logistics Support Force" with 2 trials as a collaborator, "Putuo Hospital, Shanghai University of Traditional Chinese Medicine" with 2 trials as a collaborator, "Yueyang Hospital, Shanghai University of Traditional Chinese medicine" with 2 trials as a collaborator and "Beijing Chao Yang Hospital" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Putuo District Central Hospital" are "Type 2 Diabetes" (4 trials), "Diabetes" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Atrial Fibrillation" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Shanghai Putuo District Central Hospital" in a lesser frequency.

Most popular intervention types in "Shanghai Putuo District Central Hospital" are "Drug" (16 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Degludec" (3 trials), "Insulin Glargine" (3 trials), "Placebo" (3 trials), "Insulin Lispro" (2 trials) and "LY2963016" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Putuo District Central Hospital" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Shanghai Putuo District Central Hospital". 1 are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Shanghai Putuo District Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Putuo District Central Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".